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The protein SpoIVB plays a key role in signaling in the K checkpoint of Bacillus subtilis. This regulatory
mechanism coordinates late gene expression during development in this organism and we have recently shown
SpoIVB to be a serine peptidase. SpoIVB signals by transiting a membrane, undergoing self-cleavage, and then
by an unknown mechanism activating a zinc metalloprotease, SpoIVFB, which cleaves pro-K to its active
form, K, in the outer mother cell chamber of the developing cell. In this work we have characterized the serine
peptidase domain of SpoIVB. Alignment of SpoIVB with homologues from other spore formers has allowed
site-specific mutagenesis of all potential active site residues within the peptidase domain. We have defined the
putative catalytic domain of the SpoIVB serine peptidase as a 160-amino-acid residue segment at the carboxyl
terminus of the protein. His236 and Ser378 are the most important residues for proteolysis, with Asp363 being
the most probable third member of the catalytic triad. In addition, we have shown that mutations at residues
Asn290 and His394 lead to delayed signaling in the K checkpoint. The active site residues suggest that SpoIVB
and its homologues from other spore formers are members of a new family of serine peptidases of the trypsin
superfamily.
The protein SpoIVB has recently been identified as a serine
peptidase that plays a central role in a regulatory checkpoint
(the K checkpoint) which coordinates gene expression during
the later stages of spore formation in Bacillus subtilis (36).
Proteolytic activity has been demonstrated in vitro as well as in
vivo and this activity is essential to SpoIVB’s role as the sig-
naling molecule that activates K.
SpoIVB is synthesized in the forespore chamber of the
sporulating cell and is secreted across the inner forespore
membrane. At this point SpoIVB becomes proteolytically ac-
tive and self-cleaves into at least three distinct species, of 46,
45, and 44 kDa. These are thought to be the active forms which
signal proteolytic processing of the transcription factor K.
Signaling leads to activation of a processing complex embed-
ded in the outer forespore membrane which cleaves the N-
terminal leader sequence (the pro sequence) from pro-K. The
sigma factor K is then competent to direct the final stages of
gene expression in the mother cell. Reminiscent of the blood
clotting cascades, SpoIVB is also subject to secondary prote-
olysis, which presumably inactivates SpoIVB by cleaving the
active species into 42- and 40-kDa forms (36). How SpoIVB
activates processing of pro-K is not yet clear, but genetic
evidence has shown that SpoIVB most likely interacts with one
or more members of the pro-K processing complex which is
embedded in the outer forespore membrane (7, 8, 10). These
proteins are SpoIVFB, a zinc metalloprotease which cleaves
pro-K (10, 28), and the BofA and SpoIVFA proteins, both of
which are required to inhibit activity of SpoIVFB (25, 26).
Interestingly, both SpoIVFA and BofA inhibit SpoIVFB using
their C termini, which are exposed to the space between the
inner and outer forespore membranes, and removal of either
the BofA or SpoIVFA C terminus renders SpoIVFB constitu-
tively active (12, 27, 34).
SpoIVB also carries a PDZ domain in the N-terminal half of
the polypeptide (21). PDZ domains are used by signaling mol-
ecules for protein targeting and protein-protein interactions
(18, 21, 22). In other work we have shown that this SpoIVB
PDZ domain could be involved in multiple interactions includ-
ing oligomerization, interaction with an inhibitor protein,
BofC, and activating processing of pro-K (14). The bacterial
Prc (also called Tsp) and HtrA (also called DegP) serine pep-
tidase families carry both a PDZ and peptidase domain (19,
21) and it has been shown that substrate recognition is medi-
ated by the PDZ domain (3). An attractive model for how
SpoIVB signals is that SpoIVB uses its PDZ domain to target
one or both of the SpoIVFB inhibitors (SpoIVFA and BofA)
followed by cleavage of the C termini of these inhibitors. An
alternative role for the serine peptidase activity is simply to
enable secretion of SpoIVB across the inner forespore mem-
brane since SpoIVB does not carry a normal N-terminal signal
sequence.
Homologues of SpoIVB proteins have been identified in a
number of spore-forming organisms, revealing a string of
strictly conserved residues. In this work we have examined the
serine peptidase domain of SpoIVB with the aim of defining
amino acid residues involved in catalysis. It appears that
SpoIVB is a distinctive variant of trypsin-like proteases and
that PDZ domains commonly have a specialized role in bac-
teria for the activation and substrate recognition of proteases
that have to cross a membrane.
MATERIALS AND METHODS
Bacterial strains. Strains used in this work are listed in Table 1 and were all
congenic with the prototrophic spo strain PY79. To construct lysogens of
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SP::gerE-lacZ a phage lysate was prepared from strain SC433 and used for
transduction of appropriate recipient strains. For integration of DNA at the
amyE locus, cells were transformed with linearized DNA (11). Strain construc-
tions using DNA-mediated transformation are outlined briefly in Table 1.
General methods. General Bacillus methods (transduction, transformation,
antibiotic selection, etc.) were performed as described by Cutting and Vander-
Horn (11). Sporulation methods, including the induction of sporulation by the
resuspension method, resistance measurements, and assays of gerE-directed
-galactosidase synthesis, were performed as described previously (16).
Site-specific mutagenesis. Two oligonucleotide primers were used to amplify
by PCR a 1,429-bp spoIVB product using chromosomal DNA from B. subtilis
strain PY79 as a template. The primers were P1 (5-TTATAACGTTCGTGCA
CATCCATTCGTTC-3), annealing to nucleotides 146 to 127 from the
spoIVB start codon, and P2 (5-AACGGATCCAGTCAGCTTGCTTTTTCTTT
TCC-3), which annealed to the spoIVB stop codon (bold) and a further 18 bases
downstream. The PCR product contained HindIII (P1) and BamHI (P2) restric-
tion sites (underlined), enabling direct cloning into pBluescript II KS(). The
resultant clone, pNH252, was sequenced completely to verify the presence of an
unmodified spoIVB cistron. Next, mutations were created with mismatched oli-
gonucleotides using the method of Kunkel as described in Sambrook et al. (29).
pBluescript clones were verified by the presence of a single base change by DNA
sequencing. Finally, the spoIVB genes were subcloned as 1.4-kb HindIII-BamHI
fragments into pDG364 (11) and are listed in Table 1. pDG364 enables the
insertion of cloned DNA, in trans, at the amyE locus by a double-crossover
marker replacement. In each case we linearized the pDG364 subclones by di-
gestion with XhoI and introduced them into SC1836 (spoIVB::spc) cells by
DNA-mediated transformation followed by selection for chloramphenicol resis-
tance (Cmr; encoded by pDG364). Insertion at the amyE locus was confirmed by
testing for an Amy phenotype (failure to digest starch) as described elsewhere
(11). We also constructed two isogenic control strains, NH578 (spoIVB::spc
amyE::spoIVB) and NH577 (spoIVB::spc amyE::pDG364). NH578 was created
by integrating a pDG364 subclone, pNH470, carrying the full-length, 1,429-bp,
wild-type spoIVB gene into the amyE locus and NH577 was created by integrat-
ing the unmodified pDG364 plasmid into the chromosome by a double-crossover
recombination event at amyE.
Western blotting analysis. Samples (1 ml) were taken from sporulating cul-
tures and cells were harvested by centrifugation and frozen in liquid N2. To break
cells, pellets were suspended in 50 l of TS buffer (25 mM Tris-HCl [pH 7.4], 0.1
M NaCl) containing lysozyme (0.2 g/ml) and incubated for 10 min on ice. Fifty
microliters of 2 sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) loading dye was then added and the samples were sonicated for
10 s before gel loading (approximately 20 l of sample/well). Immunoblotting of
sporulating extracts with polyclonal antiserum to SpoIVB was performed as
described previously (12, 36).
Expression of SpoIVB templates in Escherichia coli. A pET28b clone (pIVB)
containing a truncated SpoIVB template starting at codon 37 of spoIVB and
fused to the ribosome binding site and ATG start codon of the pET vector has
been described (36). Identical clones were made carrying mutant spoIVB
templates spoIVBHN236 (pIVBHN236), spoIVBDL242 (pIVBDL242),
spoIVBDL363 (pIVBDL363), and spoIVBSK378 (pIVBSK378).
RESULTS
Site-directed mutagenesis of putative peptidase catalytic
residues. Figure 1 shows a sequence alignment of the C-ter-
minal domains (residues 188 to 425 in B. subtilis SpoIVB) of
SpoIVB homologues from four Bacillus species (B. subtilis, B.
anthracis, B. stearothermophilus, and B. halodurans), two Clos-
tridium species (C. acetobutylicum and C. difficile), and Car-
boxydothermus hydrogenoformans. This region lies downstream
of the PDZ domain (residues 102 to 186 in B. subtilis SpoIVB).
The availability of sequences from such divergent sources aids
the definition of strictly conserved residues. A single serine
(Ser378) is conserved among these proteins. Proteolysis in vivo
and in vitro is inhibited by the serine peptidase inhibitor diiso-
propylfluorophosphate and a mutation at this serine (SA378)
inhibits autoproteolysis of SpoIVB (36). In addition, residues
(GMSG) flanking this serine are conserved and are reminis-
cent of the SA clan of serine peptidases, which comprise the
trypsin superfamily (1, 23) which has recently been reclassified
as clan PA(S) (24). As has been discussed previously, this is the
most likely candidate for the active site serine (36). The cata-
lytic domain of most (but not all) serine peptidases consists of
a triad of three residues (histidine, aspartic acid, and serine),
with their order and spacing defining the clan and family of the
TABLE 1. B. subtilis strains
Strain Genotype Construction or referencea
Established strains
PY79 spo 38
SC433 SP::gerE-lacZ 9
SC1836 spoIVB::spc 17
NH578 spoIVB::spc amyE::spoIVB pNH470 into SC1836
NH577 spoIVB::spc amyE::pDG364 pDG364 into SC1836
Nonconservative mutants
NH1377 spoIVB::spc amyE::spoIVBDL213 pNH1375 into SC1836
NH1320 spoIVB::spc amyE::spoIVBHN236 pNH1308 into SC1836
NH1345 spoIVB::spc amyE::spoIVBDL240 pNH1342 into SC1836
NH1346 spoIVB::spc amyE::spoIVBDL242 pNH1343 into SC1836
NH1347 spoIVB::spc amyE::spoIVBNI290 pNH1344 into SC1836
NH1380 spoIVB::spc amyE::spoIVBKA321 pNH1376 into SC1836
NH1326 spoIVB::spc amyE::spoIVBDL363 pNH1314 into SC1836
NH1328 spoIVB::spc amyE::spoIVBSK378 pNH1316 into SC1836
NH1455 spoIVB::spc amyE::spoIVBKA387 pNH1445 into SC1836
NH1330 spoIVB::spc amyE::spoIVBHD394 pNH1318 into SC1836
Conservative mutants
NH1451 spoIVB::spc amyE::spoIVBHF236 pNH1441 into SC1836
NH1452 spoIVB::spc amyE::spoIVBDN242 pNH1442 into SC1836
NH1453 spoIVB::spc amyE::spoIVBDN363 pNH1443 into SC1836
NH1454 spoIVB::spc amyE::spoIVBSA378 pNH1444 into SC1836
a Mutations were created in pBluescript clones carrying the spoIVB gene, sequenced, and subcloned into pDG364 to give the plasmid clones indicated. These
subclones were then linearized and DNA was introduced into the amyE locus of SC1836 cells as described in Materials and Methods.
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peptidase (23). Clans indicate a common evolutionary origin,
usually assigned following determination of three-dimensional
structure, while families are primarily defined by sequence
homology. The alignment reveals four conserved Asp residues
(positions 213, 240, 242, and 363) that could form the acidic
part of the catalytic triad. Only two His residues (positions 326
and 394) are conserved which could represent the base that
enhances the nucleophilicity of the active site serine. Con-
served lysine residues (positions 321 and 387) were also tar-
geted for mutagenesis as they could potentially perform the
role of a base. Examples include -lactamase and Tsp, which
have a catalytic Ser-Lys dyad (1). Similarly, the conserved
asparagine at position 290 was mutated, since Asn residues are
known to be involved in oxyanion stabilization in some pro-
teases (e.g., subtilisin) or are important in orienting catalytic
His residues in cysteine proteases. A number of conservative
and more drastic, nonconservative replacements were intro-
duced into the sites predicted to be important in catalytic
activity (Table 2).
In vivo effects of SpoIVB mutations. All mutations were
created in a pBluescript spoIVB clone, which carried the entire
spoIVB gene. The mutated spoIVB clone was sequenced to
verify the presence of a single base change and then subcloned
into the plasmid pDG364. When linearized, this plasmid en-
ables cloned DNA to be introduced at the amyE locus by a
double-crossover recombination event (11). The mutant
spoIVB alleles were incorporated at amyE in cells carrying a
null mutation at the spoIVB locus, spoIVB::spc. Using iso-
genic control strains with (NH578) or without (NH577) a copy
of the wild-type spoIVB gene at amyE we examined sporulation
and signaling.
As shown in Table 2 there were three distinct classes of
mutant phenotype. The first group (group I) consisted of
spoIVBHN236, spoIVBHF236, spoIVBDL242, spoIVBDL363,
spoIVBSA378, and spoIVBSK378 mutants which caused a se-
vere effect on spore formation, with the failure to produce
heat- or lysozyme-resistant spores. Spore formation was ar-
rested at stage III-IV with the production of limited numbers
of phase-grey spores. This phenotype was essentially asporog-
enous and indistinguishable from the null spoIVB::spc mu-
tant. The pDG364 plasmids carrying these mutant alleles were
introduced into spo cells (strain PY79) and in each case we
found that the resulting phenotype was Spo, showing that the
mutation was recessive to the wild-type spoIVB gene when
placed at its normal chromosomal position (data not shown).
The second phenotypic class (group II) was made up of
strains carrying the spoIVBDL213, spoIVBDL240, spoIVBDN242,
spoIVBKA321, spoIVBDN363, and spoIVBKA387 alleles. Cells
carrying these mutations produced normal levels of heat- and
lysozyme-resistant spores and were essentially indistinguish-
able from the isogenic Spo strain, NH578. Spores produced
in these mutants were able to germinate normally.
The final and most interesting mutant class (group III) com-
prised the spoIVBNI290 and spoIVBHD394 mutations. They
formed phase-bright spores, and so were Spo, but there was
a marked and reproducible reduction in the level of spores
produced (approximately 30% fewer spores than in the wild-
type strain). For these mutants we examined the capacity of
spores to germinate and found that they were germination
defective. Further analysis revealed that for spoIVBNI290 this
germination defect was temperature sensitive, since the mutant
was unable to germinate properly at 37°C. In other work
FIG. 1. Protein sequence alignment of SpoIVB peptidase domains. Sequences were aligned using ClustalW (32) and the figure was generated
using ALSCRIPT (2). Abbreviations: Bsub, B. subtilis (accession no. P17896, residues 187 to 425); Bhal, B. halodurans (Q9K975, 197 to 437); Cdif,
C. difficile (Q46028, 124 to 352); Bant, B. anthracis (www.tigr.org/tdb/mdb/mdbinprogress.html); Chyd, C. hydrogenoformans (www.tigr.org/tdb
/mdb/mdbinprogress.html); Bste, B. stearothermophilus (www.genome.ou/bstearo.html); Cace, C. acetobutylicum (www.genomecorp.com/genesequences
/clostridium/clospage.html). Sequences without accession numbers were derived from the unfinished genome DNA sequences. Strictly conserved amino
acids are boxed, positions of the SpoIVB mutants described are labeled and numbered, and the putative catalytic triad residues are highlighted with an
asterisk.
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we have shown that bofA and bofB mutations (in BofA
and SpoIVFA, respectively) allow constitutive activation of
SpoIVFB and therefore pro-K processing (8). This, in turn,
leads to premature K-controlled gene expression, a reduction
in spore-forming efficiency, and for those spores that are
formed (approximately 10% of the total CFU), a defective
germination response. This phenotype is most probably caused
by a defect in spore coat assembly, which is controlled by the
K regulon. We reasoned that the reduced sporulation effi-
ciency and defective germination response of the NI290 and
HD394 mutants could be caused by a defect in signaling.
K-directed gene expression. To examine signaling in the K
checkpoint we used a K-transcribed reporter gene, gerE-lacZ
(9). Lysogenized cells carrying mutant alleles with the
SPgerE-lacZ reporter phage were examined for gerE-directed
-galactosidase synthesis during spore formation (Fig. 2). For
the spoIVB null mutant (SC1836 spoIVB::spc) we detected
low levels (less than 15%) of K-directed gene expression, in
FIG. 2. gerE-lacZ expression in spoIVB mutants. -Galactosidase synthesis was measured at the indicated times following the initiation of
sporulation in cells carrying the SPgerE::lacZ reporter phage. In each case congenic strains were used and the relevant alleles (at the amyE locus)
are given here (see Table 1 for complete genotypes). (A) F, NH578, spoIVB; E, NH577, spoIVB::spc; ‚, NH1326, spoIVBDL363; Œ, NH1328,
spoIVBSK378; , NH1320, spoIVBHN236; f, NH1346, spoIVBDL242. (B) F, NH578, spoIVB; E, NH577, spoIVB::spc; , NH1345,
spoIVBDL240; f, NH1347, spoIVBNI290; ‚, NH1330, spoIVBHD394; Œ, NH1377, spoIVBDL213; {, NH1380, spoIVBKA321. (C) F, NH578,
spoIVB; E, NH577, spoIVB::spc; f, NH1451, spoIVBHF236;, NH1452, spoIVBDN242; Œ, NH1453, spoIVBDN363; ‚, NH1454, spoIVBSA378;
}, NH1455, spoIVBKA387.
TABLE 2. spoIVB alleles
Straina Relevant allele Mutationb Heatresistancec
Lysozyme
resistancec Germination phenotype
d Signalinge
NH577 spoIVB::spc Insertion-deletion 4.9  105 1.56  102 ND 
NH578 spoIVB Wild type 88 54.4  
NH1377 spoIVBDL213 Asp213 to Leu 98 94.5  
NH1320 spoIVBHN236 His236 to Asn 1.18  104 1.12  102 ND 
NH1451 spoIVBHF236 His236 to Phe 2.3  104 6.9  103 ND 
NH1345 spoIVBDL240 Asp240 to Leu 95.7 55.7  
NH1346 spoIVBDL242 Asp242 to Leu 1.12  103 2.19  102 ND 
NH1452 spoIVBDN242 Asp242 to Asn 87.6 45  
NH1347 spoIVBNI290 Asn290 to Ile 28.9 29  (30°C),  (37°C) Delayed
NH1380 spoIVBKA321 Lys321 to Ala 86 88  
NH1326 spoIVBDL363 Asp363 to Leu 1.54  104 3.7  102 ND 
NH1453 spoIVBDN363 Asp363 to Asn 77.6 42  
NH1328 spoIVBSK378 Ser378 to Lys 1.76  104 1.77  102 ND 
NH1454 spoIVBSA378 Ser378 to Ala 3.25  104 3.26  103 ND 
NH1455 spoIVBKA387 Lys387 to Ala 68.1 57  
NH1330 spoIVBHD394 His394 to Asp 26.7 34.7  (30°C),  (37°C) Delayed
a See Table 1.
b See Fig. 1.
c Heat or lysozyme resistance of cultures 24 h after the initiation of sporulation in DS medium (16). Values are expressed as percentages of CFU per milliliter in
the untreated culture.
d Five-day-old colonies grown on sporulation agar were tested for their capacity to germinate normally on tetrazolium agar plates as described previously (16). All
strains that were phenotypically Spo were not tested for a germination phenotype (ND).
e Signaling was defined according to the following two criteria: firstly, formation of pigmented colonies (Pig) associated with the production of the K-expressed
CotA protein (30), and secondly, expression of the K-controlled reporter gene, gerE-lacZ, in cells containing an SPgerE-lacZ lysogen (see Fig. 2) as described
previously (9).
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agreement with previous work, while for spo cells, gerE-lacZ
expression started at about 3.5 to 4 h after the initiation of
spore formation. Our results define three clear classes of mu-
tant gene expression, with (i) a block in K-directed gene
expression, (ii) no effect on K-directed gene expression, and
(iii) delayed and reduced levels of expression. These mutant
phenotypes correspond exactly to the groups classified above
according to their ability to sporulate.
The group I mutant strains with a null sporulation pheno-
type have essentially abolished or severely reduced gerE-lacZ
expression (Fig. 2A and C). The second group comprised the
mutants with no detectable sporulation defect. These strains
expressed gerE-lacZ at the same time and at the same levels as
in spo cells (Fig. 2B and C). The third group caused a clear
delay (1 h) and reduction in the level of gerE-lacZ expression
(Fig. 2B). As mentioned above, defective signaling can lead to
defects in spore coat assembly and spore germination. Here,
gene expression was delayed, in contrast to mutations in bofA
and bofB that allow constitutive processing of pro-K, leading
to premature K-directed gene expression. Although other
alleles within spoIVB have been shown to lead to delayed
signaling (14, 17), the clear delay seen in the spoIVBHN394
and spoIVBNI290 mutations reinforces the notion that the role
of this checkpoint is as a timing mechanism. That signaling
does occur accounts for the levels of phase-bright spores that
are produced.
Proteolysis of SpoIVB. To determine the effect of our col-
lection of mutations on proteolysis we examined SpoIVB dur-
ing spore formation using a polyclonal antiserum (Fig. 3).
Previous work has shown that SpoIVB is synthesized as a
50-kDa polypeptide at about the second hour of sporulation
(36). Starting at hour 3, SpoIVB is cleaved into a number of
products (approximately 46, 45, and 44 kDa), one or more of
which is the active form that signals SpoIVFB-mediated pro-
cessing of pro-K. Almost simultaneously, these forms are sub-
ject to secondary proteolysis, which presumably inactivates the
active forms by cleavage to 42- and 40-kDa species which are
then cleaved further. During sporulation, then, in wild-type
cells, we see the 50-kDa species briefly but at hour 3 autopro-
teolysis has begun producing the active species as well as the
inactive forms.
The effects on SpoIVB proteolysis are shown in Fig. 3. It
must be stressed that these Western blots are particularly dif-
ficult to interpret due to the appearance of intermediate spe-
cies in the blots and our accuracy in sampling. Regardless, we
have repeated these blots at least twice and are confident of
the following classifications by residue.
FIG. 3. Proteolysis of SpoIVB in B. subtilis. Sporulation was induced in wild-type (spo), spoIVB::spc (spo), and spoIVB mutant strains. Panel
A shows an experiment examining strains carrying nonconservative mutations, and panel B shows strains carrying conservative changes as well as
the alteration KA387. Samples of sporulating cells were taken at the times indicated, cells were lysed, and equivalent amounts of cellular protein
were fractionated by SDS-PAGE (12%) and examined with a polyclonal antiserum to SpoIVB (2-min enhanced chemiluminescence exposure
time). The full-length, 50-kDa, unprocessed form of SpoIVB is marked, as are 46-, 45-, and 44-kDa intermediate SpoIVB cleavage products and
the 42- and 40-kDa cleavage products produced by secondary cleavage.
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(i) His236 and Ser378. Compared to spo cells, in HN236
(Fig. 3A), HF236 (Fig. 3B), SK378 (Fig. 3A), and SA378 (Fig.
3B) mutants, the 50-kDa SpoIVB protein was cleaved less
quickly and appeared to be maintained longer in its full-length
form. Compared to spo cells the 50-kDa species appeared to
undergo proteolysis approximately 30 min later as judged by
the appearance of the 40- to 42-kDa species. This corresponds
to hour 3 using our sampling regimen shown in Fig. 3. We must
emphasize that differences in actual processing time compared
to previous studies (36) are empirical and must be taken in the
context of processing relative to that in spo cells. With some
mutants such as KA387 (Fig. 3B) and DL213 (Fig. 3A) there
appeared to be slightly more of the 50-kDa species than with
spo cells at the same time points. However, processing initi-
ated at the same time as in spo cells (2.5 h). To confirm that
proteolysis was defective in these mutant proteins, we ex-
pressed the HN236 and SK378 SpoIVB mutants from pET28b
expression vectors in E. coli BL21(DE3) and examined ex-
pressed proteins by SDS-PAGE. As shown in Fig. 4, expression
led to the accumulation of a stable, full-length 50-kDa SpoIVB
species. In contrast, expression of a wild-type SpoIVB template
produced little or no detectable SpoIVB protein as it is subject
to rapid self-cleavage in E. coli (36).
(ii) Asp213 (Fig. 3A), Asp240 (Fig. 3A), Lys321 (Fig. 3A),
and Lys387 (Fig. 3B). Processing in these mutants appeared to
be normal in terms of the onset of proteolysis and clearance of
the 50-kDa species. Our interpretation is also based on the
ability of these mutants to signal processing of pro-K nor-
mally.
(iii) Asp242. We are unable to detect any SpoIVB DL242
mutant protein in B. subtilis (Fig. 3A). We have repeated this
experiment a number of times and conclude that this mutant
protein is unstable and presumably is rapidly cleared by sec-
ondary proteolysis. We confirmed this, in part, by expressing
the SpoIVB DL242 protein in E. coli (Fig. 4), which showed
that the mutant protein behaves differently from the wild-type
protein, accumulating as a 35- to 40-kDa species. The aberrant
molecular mass of this SpoIVB DL242 species implies that
self-cleavage is defective and/or the protein is unstable. The
latter deduction could arise if the structure of the mutant
polypeptide is abnormal. This corresponds with our results
showing that signaling is defective in spoIVBDL242 cells. In
contrast, a conservative amino acid substitution at this position
(Asp242 to Asn) allows normal signaling in the K checkpoint,
and proteolysis of the SpoIVB DN242 protein appears normal.
(iv) Asn290 (Fig. 3A) and His394 (Fig. 3A). Processing of
these SpoIVB mutant proteins appeared essentially normal,
although there was perhaps a slight accumulation of the 50-
kDa species in spoIVBHD394 cells. Although signaling is de-
layed in spoIVBNI290 and spoIVBHD394 mutants, we assume
that the subtle change or delay in SpoIVB processing is not
detectable by the 30-min sampling regimen used here.
(v) Asp363. Proteolysis appeared to be delayed by 30 min in
spoIVBDL363 mutant cells (Fig. 3A). Also, there appeared to
be considerably less SpoIVB protein detectable by Western
blotting. Expression of SpoIVB DL363 in E. coli showed a
clear accumulation of a full-length 50-kDa precursor, showing
that processing was defective. In contrast, processing in the
mutant with a conservative replacement (SpoIVB DN363) was
normal (Fig. 3B), as was signaling of pro-K processing.
DISCUSSION
Our analysis of potential catalytic residues that comprise the
serine peptidase domain has provided strong evidence for
His236 and Ser378 as components of the active site, since
substitution at these positions prevents signaling of pro-K
processing as well as inhibiting the proteolytic activity of
SpoIVB. As mentioned below it must be stressed that pro-
teases can retain residual activity even when active site resi-
dues are altered (20). The order and spacing of His236 and
Ser378 agree with serine peptidases of the trypsin superfamily
(1, 23) and make the essential catalytic unit approximately 160
amino acid residues contained at the C terminus of SpoIVB.
The GMSG motif surrounding Ser378 closely resembles tryp-
sin, but it is a distinct variant as this family typically has a
residue with negative charge (Asp or Glu) preceding the active
site serine (1, 23). In contrast, there is little similarity in se-
quence around the active site SpoIVB His236 residue with
FIG. 4. Expression of mutant SpoIVB proteins in E. coli. E. coli BL21 (DE3) cells harboring pET28b vectors with a wild-type (WT) SpoIVB
or mutant genes (spoIVBHN236, spoIVBDL242, spoIVBDL363, and spoIVBSK378) were grown and gene expression was induced with isopropyl-
-D-thiogalactopyranoside (IPTG). Samples taken before induction (T0) and at hours 1 (T1) and 2 (T2) postinduction were fractionated by
SDS-PAGE (12.5%). The full-length 50-kDa SpoIVB precursor protein is indicated by an arrow.
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other trypsin family members, suggesting that SpoIVB must be
a member of a new family of the PA(S) clan.
We have identified one Asp residue, Asp363, for which mu-
tation to Leu leads to a lack of SpoIVB self-cleavage and
signaling properties. Another Asp residue, Asp242, when mu-
tated to Leu also blocked signaling yet failed to accumulate any
protein at all, suggesting that the mutation rendered the pro-
tein unstable. We have noticed a DxxLL motif which is present
in a number of serine peptidase families, especially those of the
PA(S) clan (23, 24), and is found at position 363, and we take
this as evidence that the SpoIVB serine peptidase has a cata-
lytic triad with Asp363 as its third member. Intriguingly, a
conservative change at this position does not disrupt proteol-
ysis of the SpoIVB protein. The acidic residue is the least
important component of the active site triad in serine pepti-
dases, and Asp is replaced by Glu in carboxyl peptidase (37)
and aspartyl dipeptidase (13). In the case of cytomegalovirus
protease, histidine acts as the acid in a unique Ser-His-His
triad. Mutation of cytomegalovirus protease His157 reduces
activity only 5- to 10-fold (33). In contrast, catalysis by trypsin-
like enzymes is severely impaired when the acidic residue is
replaced by mutation, suggesting that the negative charge of
the Asp side chain balances the positive charge that develops
on the histidine during catalysis (6). In some systems, however,
the Asp simply serves to maintain the correct position of the
active site histidine. Indeed, in cysteine proteases, a conserved
Asn residue (e.g., Asn175 in papain) serves this very purpose
(35) and Asn156 appears in the hydrolase catalytic triad of E.
coli outer membrane phospholipase A (15). We assume that
the role of Asp363 is to stabilize the appropriate His263 rota-
mer or tautomer in SpoIVB catalysis, a function that could
potentially be performed by Asn. The unusually close spacing
of Asp363 to Ser378, its ability to be replaced by Asn, and the
lack of a consensus motif around His236 all argue that SpoIVB
represents a new family of serine peptidases.
One observation we have made here is that mutations that
block signaling of pro-K processing underwent proteolysis in
B. subtilis to yield intermediate forms. We have not noticed this
before with a different spoIVBSA378 mutant which was placed
at the spoIVB locus (36). We believe that one possible expla-
nation is that even though an active site residue is mutated, the
protease can still retain residual proteolytic activity (20). De-
spite mutation of all three members of the catalytic His-Asp-
Ser triad of subtilisin, enzymatic activity is still approximately
103 to 104 times the noncatalyzed rate (5). Our in vivo work
shows that changes at His236, Asp363, and Ser378 do appear
to allow limited self-cleavage of SpoIVB to forms of approxi-
mately 46, 45, and 44 kDa. We had previously predicted that
FIG. 5. Bacterial proteases with PDZ domains. Bacterial PDZ-containing proteins detected by the simple modular architecture research tool
(SMART) (31) that are associated with peptidase activity are represented schematically with the number of proteins (as of June 2001) of each type
indicated. Non-SpoIVB proteins are classified into three groups characterized by trypsin modules (Trp), carboxyl-terminal processing peptidases
(Tsp), or zinc metallopeptidases (Zn). For simplicity, ST represents either a signal or transit peptide or a membrane-spanning segment. Also, only
the transmembrane segments (TM) that are accurately predicted by SMART are represented for ease of comparison.
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these might represent active forms but we must now question
this model. It is possible, though, that the 44- to 46-kDa species
observed in these mutants are actually inactive forms brought
about by incorrect cleavage or by secondary proteolysis. Alter-
natively, residual enzyme activity is sufficient to permit self-
cleavage but at levels too low to permit signaling. Our work
does show clearly, though, that all nonsignaling mutants show
delayed cleavage of the full-length form of SpoIVB, and we
wonder whether signaling can occur only during a precise win-
dow of time concurrent with release of SpoIVB from the inner
forespore membrane by self-cleavage. This latter event would
occur following the first cut, and for signaling this is presum-
ably then the most important event, enabling release of
SpoIVB. In the nonsignaling mutants, though, we reason that
self-processing is substantially reduced, leading to a delayed
appearance of intermediate species, at which time the
SpoIVFB processing complex is no longer responsive (or com-
petent) to cleave pro-K.
The results of mutation at residues Asn290 and His394 are
more difficult to interpret. Our work suggests that proteolysis
of these mutants was less potent, leading to delayed signaling.
Possible explanations include roles for these residues in
ground state substrate binding or stabilization of the reaction
transition state by forming an oxyanion hole reminiscent of
Asn155 in subtilisin. Mutation of this sidechain leads to a 200-
to 300-fold reduction in turnover number of this serine pepti-
dase (4). A similar role for Asn290 might explain a delay in
signaling.
We are presently attempting to determine the crystal struc-
ture of SpoIVB, which will enable us to test our prediction that
Asp363 is suitably placed to comprise the third member of a
catalytic triad and to assess the importance of residues Asn290
and His394 in SpoIVB function. We will also explore the role
of the PDZ domain in relation to the peptidase activity. A
survey of bacterial proteins with PDZ domains suggests that of
187 non-SpoIVB bacterial PDZ-containing proteins, remark-
ably only 9 are predicted not to contain transit peptides or
transmembrane segments. More surprising is that only 28 are
not associated with a protease activity, i.e., 85% of all known
PDZ-containing bacterial proteins are also proteases (Fig. 5),
indicating that they have evolved a specialized role in associ-
ation with peptidase activity due to their ability to traverse a
membrane for (i) localization and (ii) substrate specificity, and
thus are ideal for the signaling function of SpoIVB.
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